We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DERM market cap is 64.96M. The company's latest EPS is USD -0.2082 and P/E is -16.86.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.12M | 18.6M | 12.21M | 17.17M | 34.54M |
| Operating Income | -9.49M | -7.37M | -9.56M | -7.65M | 17.25M |
| Net Income | -10.08M | -10.64M | -10.14M | -8.36M | 16.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.92M | 44.53M | 63.13M | 73.67M | 79.18M |
| Operating Income | 5.26M | 7.85M | -34.88M | -27.52M | -2.07M |
| Net Income | 3.63M | 5.28M | -43.99M | -29.63M | -3.85M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 108.15M | 105.16M | 95.85M | 69.75M | 65.92M |
| Total Liabilities | 81.96M | 88.18M | 88.36M | 69.74M | 48.54M |
| Total Equity | 26.18M | 16.98M | 7.49M | 5k | 17.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.86M | 51.91M | 97.28M | 105.16M | 76.85M |
| Total Liabilities | 31.11M | 41.61M | 55.24M | 88.18M | 56.5M |
| Total Equity | 2.75M | 10.29M | 42.04M | 16.98M | 20.35M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.7M | -13.53M | -956k | 3.01M | 21.76M |
| Investing | -20M | -20M | -5M | -5M | -5M |
| Financing | 15.51M | 16.46M | 52k | -13.04M | -24.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.02M | 5.13M | -2.18M | -13.53M | 5.24M |
| Investing | -2.4M | -1.2M | -10M | -20M | -5M |
| Financing | -3.55M | -487k | 53.02M | 16.46M | -4.8M |
| Market Cap | 64.96M |
| Price to Earnings Ratio | -16.86 |
| Price to Sales Ratio | 0.82 |
| Price to Cash Ratio | 2.37 |
| Price to Book Ratio | 3.19 |
| Dividend Yield | - |
| Shares Outstanding | 18.51M |
| Average Volume (1 week) | 80.74k |
| Average Volume (1 Month) | 164.67k |
| 52 Week Change | 126.45% |
| 52 Week High | 8.11 |
| 52 Week Low | 1.02 |
| Spread (Intraday) | 0.31 (8.05%) |
| Company Name | Journey Medical Corporation |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://journeymedicalcorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
